Moreover, we have previously shown that the treatment of AD mice with the peptide containing the extracellular domain of p75NTR fused to human Fc region (p75ECD-Fc) reduced Tau hyperphosphorylation and Aβ plaque formation and reversed cognitive impairments [33]. Here, MAPT is linked to Alzheimer disease.